Financial Performance - The company's operating revenue for Q3 2022 was ¥17,735,740.08, a decrease of 45.52% compared to the same period last year[5] - The net profit attributable to shareholders for Q3 2022 was ¥1,714,535.51, down 87.75% year-on-year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses for Q3 2022 was -¥3,685,644.11, a decline of 126.64% compared to the previous year[5] - Total operating revenue for the first three quarters of 2022 was CNY 103,478,435.04, a decrease of 22.6% compared to CNY 133,969,504.28 in the same period of 2021[22] - Net profit for the third quarter of 2022 was CNY 41,675,153.77, a decline of 33.8% from CNY 62,915,181.87 in the same quarter of 2021[23] - The total comprehensive income attributable to the parent company for Q3 2022 was CNY 41,675,153.77, compared to CNY 62,915,181.87 in Q3 2021, reflecting a decrease of approximately 33.7%[24] - Basic and diluted earnings per share for Q3 2022 were both CNY 0.78, down from CNY 1.35 in Q3 2021, indicating a decline of about 42.4%[24] Research and Development - The total R&D investment for Q3 2022 was ¥12,950,712.10, an increase of 87.88% year-on-year, representing 73.02% of operating revenue[6] - Research and development expenses for the first three quarters of 2022 amounted to CNY 29,395,811.27, an increase of 66.6% compared to CNY 17,658,921.30 in 2021[22] - The company plans to continue increasing R&D investment to enhance product development and market competitiveness[11] - The company is focused on expanding its market presence and enhancing its product offerings through ongoing research and development efforts[14] Assets and Liabilities - The total assets at the end of the reporting period were ¥1,338,747,441.72, an increase of 248.93% compared to the end of the previous year[6] - Total assets as of the end of the third quarter of 2022 were CNY 1,338,747,441.72, significantly higher than CNY 383,671,323.60 at the end of the same period in 2021[21] - Total liabilities decreased to CNY 10,059,163.23 in the third quarter of 2022 from CNY 20,583,832.52 in the same quarter of 2021, a reduction of 51.1%[20] Cash Flow - The cash flow from operating activities for the year-to-date was -¥16,077,406.01, a decline of 129.28%[6] - Cash inflow from operating activities for the first nine months of 2022 was CNY 122,073,454.24, a decrease of 30.5% from CNY 175,661,977.10 in the same period of 2021[27] - The net cash flow from operating activities for the first nine months of 2022 was negative CNY 16,077,406.01, compared to a positive CNY 54,908,069.56 in the same period of 2021[27] - Cash inflow from investment activities for the first nine months of 2022 was CNY 513,268,938.45, an increase from CNY 430,200,019.15 in the same period of 2021[27] - The net cash flow from investment activities for the first nine months of 2022 was negative CNY 236,653,445.48, an improvement from negative CNY 272,714,521.85 in the same period of 2021[28] - Cash inflow from financing activities for the first nine months of 2022 was CNY 948,428,416.00, significantly higher than CNY 147,600,000.00 in the same period of 2021, marking an increase of approximately 542.5%[28] - The net increase in cash and cash equivalents for the first nine months of 2022 was CNY 665,672,051.80, compared to a decrease of CNY 71,891,048.68 in the same period of 2021[28] - The ending balance of cash and cash equivalents as of September 30, 2022, was CNY 941,294,899.39, a substantial increase from CNY 2,778,212.34 at the end of the same period in 2021[28] Shareholder Information - The company has a total of 9,919 common shareholders at the end of the reporting period[13] - The largest shareholder, Lü Hanquan, holds 28,800,000 shares, representing 43.27% of the total shares[13] Management Changes - The financial director and board secretary resigned, with the chairman Lü Hanquan temporarily taking over these responsibilities[16] Strategic Initiatives - The company has a strategic plan involving the participation of core employees in the strategic placement of shares[14] - The company has approved the use of temporarily idle raised funds for cash management as of July 29, 2022[15] - The company attributed the decline in revenue and profit to overall industry supply-demand conditions, market demand, and the impact of the pandemic[11] - The company plans to focus on market expansion and new product development in the upcoming quarters[22]
晶华微(688130) - 2022 Q3 - 季度财报